U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07153185) titled 'Creos Xenoprotect PMCF' on Aug. 15.
Brief Summary: The goal of this retrospective PMCF study is to assess safety and performance of creos xenoprotect in all indications functioning as dental barrier membrane.
The primary endpoint of the study is the occurrence of major complications during 6 months after creos xenoprotect placement whereas the hypothesis is that these major complications occur in less than 5% within this timeframe.
This is a retrospective, multicenter clinical investigation with consecutive cases. Data will be collected on consecutive data cases from patient files, given that these patients were treated within a d...